Literature DB >> 26676145

Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.

David G Allen1, Nicholas P Whitehead1, Stanley C Froehner1.   

Abstract

Dystrophin is a long rod-shaped protein that connects the subsarcolemmal cytoskeleton to a complex of proteins in the surface membrane (dystrophin protein complex, DPC), with further connections via laminin to other extracellular matrix proteins. Initially considered a structural complex that protected the sarcolemma from mechanical damage, the DPC is now known to serve as a scaffold for numerous signaling proteins. Absence or reduced expression of dystrophin or many of the DPC components cause the muscular dystrophies, a group of inherited diseases in which repeated bouts of muscle damage lead to atrophy and fibrosis, and eventually muscle degeneration. The normal function of dystrophin is poorly defined. In its absence a complex series of changes occur with multiple muscle proteins showing reduced or increased expression or being modified in various ways. In this review, we will consider the various proteins whose expression and function is changed in muscular dystrophies, focusing on Ca(2+)-permeable channels, nitric oxide synthase, NADPH oxidase, and caveolins. Excessive Ca(2+) entry, increased membrane permeability, disordered caveolar function, and increased levels of reactive oxygen species are early changes in the disease, and the hypotheses for these phenomena will be critically considered. The aim of the review is to define the early damage pathways in muscular dystrophy which might be appropriate targets for therapy designed to minimize the muscle degeneration and slow the progression of the disease.
Copyright © 2016 the American Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26676145      PMCID: PMC4698395          DOI: 10.1152/physrev.00007.2015

Source DB:  PubMed          Journal:  Physiol Rev        ISSN: 0031-9333            Impact factor:   37.312


  535 in total

1.  Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex.

Authors:  B J Hillier; K S Christopherson; K E Prehoda; D S Bredt; W A Lim
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

2.  Uncontrolled calcium sparks act as a dystrophic signal for mammalian skeletal muscle.

Authors:  Xu Wang; Noah Weisleder; Claude Collet; Jingsong Zhou; Yi Chu; Yutaka Hirata; Xiaoli Zhao; Zui Pan; Marco Brotto; Heping Cheng; Jianjie Ma
Journal:  Nat Cell Biol       Date:  2005-04-17       Impact factor: 28.824

3.  Myocilin interacts with syntrophins and is member of dystrophin-associated protein complex.

Authors:  Myung Kuk Joe; Changwon Kee; Stanislav I Tomarev
Journal:  J Biol Chem       Date:  2012-02-25       Impact factor: 5.157

4.  Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS.

Authors:  Mary Lynn Mercado; Alison R Amenta; Hiroki Hagiwara; Michael S Rafii; Beatrice E Lechner; Rick T Owens; David J McQuillan; Stanley C Froehner; Justin R Fallon
Journal:  FASEB J       Date:  2006-06-28       Impact factor: 5.191

5.  Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle.

Authors:  G D Thomas; R G Victor
Journal:  J Physiol       Date:  1998-02-01       Impact factor: 5.182

6.  Increased calcium entry into dystrophin-deficient muscle fibres of MDX and ADR-MDX mice is reduced by ion channel blockers.

Authors:  O Tutdibi; H Brinkmeier; R Rüdel; K J Föhr
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

7.  Drug trial of superoxide dismutase in Duchenne's muscular dystrophy.

Authors:  L Z Stern; S P Ringel; F A Ziter; K B Menander-Huber; V Ionasescu; R J Pellegrino; R D Snyder
Journal:  Arch Neurol       Date:  1982-06

8.  The role of elevations in intracellular [Ca2+] in the development of low frequency fatigue in mouse single muscle fibres.

Authors:  E R Chin; D G Allen
Journal:  J Physiol       Date:  1996-03-15       Impact factor: 5.182

9.  Mice lacking Homer 1 exhibit a skeletal myopathy characterized by abnormal transient receptor potential channel activity.

Authors:  Jonathan A Stiber; Zhu-Shan Zhang; Jarrett Burch; Jerry P Eu; Sarah Zhang; George A Truskey; Malini Seth; Naohiro Yamaguchi; Gerhard Meissner; Ripal Shah; Paul F Worley; R Sanders Williams; Paul B Rosenberg
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

10.  Differential association of syntrophin pairs with the dystrophin complex.

Authors:  M F Peters; M E Adams; S C Froehner
Journal:  J Cell Biol       Date:  1997-07-14       Impact factor: 10.539

View more
  134 in total

1.  Single SERCA2a Therapy Ameliorated Dilated Cardiomyopathy for 18 Months in a Mouse Model of Duchenne Muscular Dystrophy.

Authors:  Nalinda B Wasala; Yongping Yue; William Lostal; Lakmini P Wasala; Nandita Niranjan; Roger J Hajjar; Gopal J Babu; Dongsheng Duan
Journal:  Mol Ther       Date:  2020-01-10       Impact factor: 11.454

2.  Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.

Authors:  Angus Lindsay; Alexandra Schmiechen; Christopher M Chamberlain; James M Ervasti; Dawn A Lowe
Journal:  Exp Physiol       Date:  2018-07       Impact factor: 2.969

3.  Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype.

Authors:  Sandra Murphy; Margit Zweyer; Maren Raucamp; Michael Henry; Paula Meleady; Dieter Swandulla; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2019-03-19       Impact factor: 2.698

4.  Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin.

Authors:  Sandra Murphy; Heinrich Brinkmeier; Mirjam Krautwald; Michael Henry; Paula Meleady; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2017-08-12       Impact factor: 2.698

5.  Photobiomodulation therapy protects skeletal muscle and improves muscular function of mdx mice in a dose-dependent manner through modulation of dystrophin.

Authors:  Gianna Móes Albuquerque-Pontes; Heliodora Leão Casalechi; Shaiane Silva Tomazoni; Andrey Jorge Serra; Cheila de Sousa Bacelar Ferreira; Rodrigo Barbosa de Oliveira Brito; Brunno Lemes de Melo; Adriane Aver Vanin; Kadma Karênina Damasceno Soares Monteiro; Humberto Dellê; Lucio Frigo; Rodrigo Labat Marcos; Paulo de Tarso Camillo de Carvalho; Ernesto Cesar Pinto Leal-Junior
Journal:  Lasers Med Sci       Date:  2017-12-05       Impact factor: 3.161

Review 6.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

Review 7.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

8.  Validation of ultrasonography for non-invasive assessment of diaphragm function in muscular dystrophy.

Authors:  Nicholas P Whitehead; Kenneth L Bible; Min Jeong Kim; Guy L Odom; Marvin E Adams; Stanley C Froehner
Journal:  J Physiol       Date:  2016-10-13       Impact factor: 5.182

9.  Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle.

Authors:  Erik P Rader; Rolf Turk; Tobias Willer; Daniel Beltrán; Kei-Ichiro Inamori; Taylor A Peterson; Jeffrey Engle; Sally Prouty; Kiichiro Matsumura; Fumiaki Saito; Mary E Anderson; Kevin P Campbell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-13       Impact factor: 11.205

10.  Autophagy regulates satellite cell ability to regenerate normal and dystrophic muscles.

Authors:  E Fiacco; F Castagnetti; V Bianconi; L Madaro; M De Bardi; F Nazio; A D'Amico; E Bertini; F Cecconi; P L Puri; L Latella
Journal:  Cell Death Differ       Date:  2016-07-22       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.